Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy

Martha B. Roach, William J. George, T. Ernesto Figueroa, Durwood Earnest Neal, Dan McBride

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Consecutive patients with abnormal rectal examinations underwenttransrectal needle prostate biopsy at VA Medical Center, New Orleans. Each patient was randomized to receive either gentamicin 1.5 mg/kg intravenously (IV) or 500 mg ciprofloxacin (Cipro-Miles) p.o., before and after the biopsy. Serum and prostate tissue levels of ciprofloxacin and gentamicin were measured by high-pressure liquid chromatography and by competitive binding immunoassay, respectively. Blood cultures were obtained, and the patients were observed for twenty-four hours after biopsy. After discharge the patients were followed up by telephone. The incidence of bacteremia and postbiopsy symptoms were less with ciprofloxacin. Prostate tissue levels of this drug were higher than gentamicin, while serum levels were roughly equivalent. Ciprofloxacin is less nephrotoxic, can be given orally, and has a better antimicrobial spectrum. We, therefore, recommend it as prophylaxis against bacteremia in transrectal prostate needle biopsy. Furthermore, it appears that prostatic drug levels are more important than serum levels in preventing bacteremia.

Original languageEnglish (US)
Pages (from-to)84-87
Number of pages4
JournalUrology
Volume38
Issue number1
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Needle Biopsy
Ciprofloxacin
Bacteremia
Gentamicins
Prostate
Serum
Biopsy
Competitive Binding
Patient Discharge
Immunoassay
Telephone
Pharmaceutical Preparations
High Pressure Liquid Chromatography
Incidence

ASJC Scopus subject areas

  • Urology

Cite this

Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy. / Roach, Martha B.; George, William J.; Figueroa, T. Ernesto; Neal, Durwood Earnest; McBride, Dan.

In: Urology, Vol. 38, No. 1, 01.01.1991, p. 84-87.

Research output: Contribution to journalArticle

Roach, Martha B. ; George, William J. ; Figueroa, T. Ernesto ; Neal, Durwood Earnest ; McBride, Dan. / Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy. In: Urology. 1991 ; Vol. 38, No. 1. pp. 84-87.
@article{a0bfe4491c25476db1cc8f92ab40a15b,
title = "Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy",
abstract = "Consecutive patients with abnormal rectal examinations underwenttransrectal needle prostate biopsy at VA Medical Center, New Orleans. Each patient was randomized to receive either gentamicin 1.5 mg/kg intravenously (IV) or 500 mg ciprofloxacin (Cipro-Miles) p.o., before and after the biopsy. Serum and prostate tissue levels of ciprofloxacin and gentamicin were measured by high-pressure liquid chromatography and by competitive binding immunoassay, respectively. Blood cultures were obtained, and the patients were observed for twenty-four hours after biopsy. After discharge the patients were followed up by telephone. The incidence of bacteremia and postbiopsy symptoms were less with ciprofloxacin. Prostate tissue levels of this drug were higher than gentamicin, while serum levels were roughly equivalent. Ciprofloxacin is less nephrotoxic, can be given orally, and has a better antimicrobial spectrum. We, therefore, recommend it as prophylaxis against bacteremia in transrectal prostate needle biopsy. Furthermore, it appears that prostatic drug levels are more important than serum levels in preventing bacteremia.",
author = "Roach, {Martha B.} and George, {William J.} and Figueroa, {T. Ernesto} and Neal, {Durwood Earnest} and Dan McBride",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0090-4295(91)80024-2",
language = "English (US)",
volume = "38",
pages = "84--87",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy

AU - Roach, Martha B.

AU - George, William J.

AU - Figueroa, T. Ernesto

AU - Neal, Durwood Earnest

AU - McBride, Dan

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Consecutive patients with abnormal rectal examinations underwenttransrectal needle prostate biopsy at VA Medical Center, New Orleans. Each patient was randomized to receive either gentamicin 1.5 mg/kg intravenously (IV) or 500 mg ciprofloxacin (Cipro-Miles) p.o., before and after the biopsy. Serum and prostate tissue levels of ciprofloxacin and gentamicin were measured by high-pressure liquid chromatography and by competitive binding immunoassay, respectively. Blood cultures were obtained, and the patients were observed for twenty-four hours after biopsy. After discharge the patients were followed up by telephone. The incidence of bacteremia and postbiopsy symptoms were less with ciprofloxacin. Prostate tissue levels of this drug were higher than gentamicin, while serum levels were roughly equivalent. Ciprofloxacin is less nephrotoxic, can be given orally, and has a better antimicrobial spectrum. We, therefore, recommend it as prophylaxis against bacteremia in transrectal prostate needle biopsy. Furthermore, it appears that prostatic drug levels are more important than serum levels in preventing bacteremia.

AB - Consecutive patients with abnormal rectal examinations underwenttransrectal needle prostate biopsy at VA Medical Center, New Orleans. Each patient was randomized to receive either gentamicin 1.5 mg/kg intravenously (IV) or 500 mg ciprofloxacin (Cipro-Miles) p.o., before and after the biopsy. Serum and prostate tissue levels of ciprofloxacin and gentamicin were measured by high-pressure liquid chromatography and by competitive binding immunoassay, respectively. Blood cultures were obtained, and the patients were observed for twenty-four hours after biopsy. After discharge the patients were followed up by telephone. The incidence of bacteremia and postbiopsy symptoms were less with ciprofloxacin. Prostate tissue levels of this drug were higher than gentamicin, while serum levels were roughly equivalent. Ciprofloxacin is less nephrotoxic, can be given orally, and has a better antimicrobial spectrum. We, therefore, recommend it as prophylaxis against bacteremia in transrectal prostate needle biopsy. Furthermore, it appears that prostatic drug levels are more important than serum levels in preventing bacteremia.

UR - http://www.scopus.com/inward/record.url?scp=0025827279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025827279&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(91)80024-2

DO - 10.1016/0090-4295(91)80024-2

M3 - Article

C2 - 1866869

AN - SCOPUS:0025827279

VL - 38

SP - 84

EP - 87

JO - Urology

JF - Urology

SN - 0090-4295

IS - 1

ER -